ATP1A3 and neoplasm: Univariate analysis identified primary therapy outcome (p < 0.001), residual tumor (p < 0.001), ATP1A3 (p = 0.002), and ATP1A4 (p = 0.023) as prognostic factors for DSS (Table 3).